Dipartimento di Ematologia, Oncologia e Medicina Molecolare, Istituto Superiore di Sanità, Rome, Italy.
Ann Ist Super Sanita. 2014;50(2):178-85. doi: 10.4415/ANN_14_02_12.
Since 2002, the European Strategy Forum on Research Infrastructures identified the needs for Research Infrastructures (RIs) in Europe in priority fields of scientific research and drafted a strategic document, the ESFRI Roadmap, defining the specific RIs essential to foster European research and economy. The Biological and Medical Sciences RIs (BMS RIs) were developed thanks to the active participation of many institutions in different European member states associated to address the emerging needs in biomedicine and, among these, the Italian National Institute of Health (ISS), in virtue of its role in public health and research, has been specifically involved in the national development and implementation of three RIs: the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), the European Advanced Translational Research Infrastructure in Medicine (EATRIS) and the European Clinical Research Infrastructures Network (ECRIN).
This article outlines the design and development of these RIs up to the recent achievement of the ERIC status, their importance in the Horizon 2020 programme and their societal and economic potential impact, with special attention to their development and significance in Italy.
The ISS plays a unique role in fostering a coordinated participation of excellence Italian institutes/facilities to different European biomedical RIs, thus contributing to health innovation, healthcare optimization, and healthcare cost containment.
自 2002 年以来,欧洲研究基础设施战略论坛确定了欧洲优先科研领域的研究基础设施(RI)需求,并起草了一份战略文件,即 ESFRI 路线图,确定了促进欧洲研究和经济发展所必需的特定 RI。生物和医学科学 RI(BMS RI)的发展得益于许多欧洲成员国相关机构的积极参与,以满足生物医学领域的新需求,其中,意大利国家卫生研究所(ISS)凭借其在公共卫生和研究方面的作用,特别参与了三个 RI 的国家发展和实施:生物银行和生物分子资源研究基础设施(BBMRI)、欧洲高级转化医学研究基础设施(EATRIS)和欧洲临床研究基础设施网络(ECRIN)。
本文概述了这些 RI 的设计和开发,直至最近获得 ERIC 地位,以及它们在 Horizon 2020 计划中的重要性及其对社会和经济的潜在影响,特别关注它们在意大利的发展和意义。
ISS 在促进意大利优秀机构/设施协调参与不同的欧洲生物医学 RI 方面发挥着独特的作用,从而为医疗创新、优化医疗保健和控制医疗保健成本做出贡献。